Redeye finds Alelion’s Q4 report encouraging, as series production and billing started in December, resulting in net sales of SEK 8.5m. Costs came in slightly higher than expected, to support the increased activity which dampened the previous cost control improvements we have seen throughout the year. Write-downs corresponding to SEK -20.1m took place in the quarter, related to previously acquired assets and inventory (previous generation batteries). Going forward, we expect additional orders to be booked, which we already saw on January 25th, as Terberg placed an additional follow-up order of SEK 8m.